Antibodies and heart effects in breast or colorectal cancer
Part of Cancer, Digestive system, Genetic & congenital, Heart & circulation clinical trials.
This study looks for a specific type of antibody (a protein made by your immune system) that may affect the heart in people with breast or colorectal cancer. The goal is to understand if these antibodies can cause heart rhythm or function changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with breast cancer or colorectal cancer, which may have spread or not.
- You are currently getting your first treatment for this cancer.
- You do not have serious heart problems like atrial fibrillation, heart failure, or certain heart muscle diseases.
- You do not have any known autoimmune diseases or immune system problems.
- You are not taking high-dose immune-suppressing drugs or other experimental treatments that could affect the study results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for hidden heart rhythm problems in adults. It involves simple tests to find conditions that might otherwise go unnoticed.
This study looks at how breast cancer medicines affect the heart. It may help doctors better prevent, spot early, and manage heart side effects from trastuzumab and/or anthracycline chemotherapy.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This trial studies how a blood test marker (TRPC6) may help predict and prevent heart muscle damage and heart failure related to some breast cancer medicines. You may join if you’re starting or have received treatment that can stress the heart, or if you already have signs of treatment-related heart problems.
This study looks for early warning signs (biomarkers) of heart damage caused by cancer treatments. It is for people who have had cancer treatment, may have heart issues, or are about to start a treatment that could affect the heart.
This study looks at whether a simple blood test can spot early signs of heart damage from certain breast cancer treatments (anthracycline chemo or anti-HER2 drugs). The goal is to protect your heart while you get the cancer treatment you need.
Hear when a new Brugada Syndrome (BrS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.